Skip to main content
. Author manuscript; available in PMC: 2018 Jun 4.
Published in final edited form as: Horm Behav. 2017 Jan 4;89:130–136. doi: 10.1016/j.yhbeh.2016.12.015

Figure 4.

Figure 4

(Left) PD10-11 mothers that received a bilateral infusion of an OT-R antagonist into the mPFC immediately before the EDS phase of the attentional set shifting task required more trials to reach criterion than PD10-11 mothers that received a bilateral saline infusion. The number of trials to reach criterion for the other task phases did not differ between saline and OT-R antagonist mothers. (Right) Locations of cannula placements within the mPFC. White circles = saline; Black circles = OT-R antagonist. Bars represent mean + SEM, * p < 0.05.